During the height of the COVID-19 pandemic, many committees and organisations were working around the clock to prepare the country for the rollout of COVID-19 vaccines. Professor Hannelie Meyer, a pharmacist-turned-academic and later vaccine advocate, served on several of these committees. Elri Voigt spoke to Meyer about the pandemic, the mottos that guide her, and being an unapologetic workaholic.
The African Christian Democratic Party and partners are in the High Court today and tomorrow seeking to stop the rollout of COVID-19 vaccines to adolescents. But in a context where the majority of learners attend schools with infrastructure problems and serious overcrowding, vaccines remain a critical tool to keep learners safe and prevent outbreaks of infection at schools, argue Julia Chaskalson and Zeenat Sujee.
The North West has passed the one million mark for COVID-19 jabs administered. Nthusang Lefafa unpacks the vaccination numbers, reasons for the province having some of the lowest vaccination numbers in the country, and how it is working to catch up.
Initially hamstrung by low and uncertain supplies of COVID-19 vaccines, government is arguably now in a better position to campaign actively to accelerate vaccine demand, albeit in the midst of an often-harmful viral “infodemic”. Chris Bateman asks what can be done to boost demand for the jab.
Just 54% of people in South Africa over the age of 50 have received at least one COVID-19 jab, with significant variation between provinces, as experts warn of the possibility of another wave of COVID-19 in future. Chris Bateman reports.
The Western Cape Department of Health has identified Khayelitsha and Mitchell’s Plain as the areas with the lowest vaccinations and vaccine registrations in the Cape Town metro. By Monday 30 August, only 22.37% of Mitchell’s Plain’s vaccine-eligible population older than 18 years have registered. In Khayelitsha, this number stood at 12.05%. Siyabonga Kamnqa visited the two areas to find out more.
Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.
From paintings by artists like Xolani Sivunda to communication campaigns launched by provincial health departments, the fight against COVID-19-related misinformation is being fought on many fronts. Siyabonga Kamnqa surveyed some of these efforts and asked health and behaviour experts what does and does not work.
The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in South Africa once registered. Adele Baleta reports.
A recent global online survey suggests that more than a third of South Africans would not want a COVID-19 vaccine if and when it becomes available. Adele Baleta reports on vaccine hesitancy in South Africa.